L26/P-458 The BMI curve for reproductive success: identifying the optimal and safe zone in 16000+ IVF cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Parmar und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How does BMI influence baseline reproductive characteristics and IVF outcomes across underweight, normal-weight, overweight, and obesity categories? Summary answer BMI extremes showed higher biochemical loss and lower clinical pregnancy rates, while normal-weight and overweight groups had the most favourable outcomes. What is known already Body mass index (BMI) influences reproductive physiology and ART outcomes through hormonal, metabolic, and inflammatory pathways. Studies show that obesity reduces clinical pregnancy and live birth and increases miscarriage after IVF, with effects evident even without medical comorbidities. Evidence for underweight is mixed in fresh cycles, but FET meta-analyses report lower live birth for underweight and obese women. Classic and updated reviews consistently associate BMI ≥25 with impaired ART outcomes, but the shape of risk (linear vs U-shaped) and the relative roles of ovarian reserve, endometrial milieu, and systemic factors remain debated. Study design, size, duration Retrospective cohort of 16,152 IVF cycles stratified by BMI: underweight (n = 644), normal weight (n = 6,788), overweight (n = 6,002), and obesity (n = 2,718). Baseline characteristics and reproductive outcomes were compared across groups. Participants/materials, setting, methods All women visiting clinical for infertility treatment across various centres. The data was collected from January 2019 to December 2025 from centralised HIS system maintained by hospital . All women were stimulated exclusively using an antagonist protocol, with no variation in stimulation regimen, medication strategy, or clinical decision pathways between centers. Main results and the role of chance Female age rose progressively with BMI (p < 0.001), mirrored by male age. AMH differed slightly across BMI (3.6–3.7 ng/mL; p = 0.021) with negligible clinical impact. Endometrial thickness varied modestly (8.6–8.86 mm; p = 0.008). Biochemical pregnancy rates were similar across BMI (69.3%–71.4%; p = 0.648) and implantation rates showed no directional trend (56.9%–58.7%). In contrast, biochemical loss displayed a U-shape (p < 0.001): highest in underweight (35.8%) and obese (23.1%) groups, substantially lower in normal-weight (3.8%) and overweight (6.2%). Clinical pregnancy differed significantly (p < 0.001): normal-weight (68.6%) and overweight (66.9%) were highest; underweight (44.4%) and obese (54.4%) were reduced, indicating poorer progression from biochemical to clinical gestation at BMI extremes. These data suggest that early loss at BMI extremes is unlikely driven by AMH or small endometrial thickness differences; rather, systemic metabolic/inflammatory factors may predominate. Clinically, findings support proactive BMI optimization before treatment, emphasizing tailored nutritional counseling, metabolic assessment, and closer luteal/early pregnancy support, especially for underweight and obese patients. Limitations, reasons for caution Retrospective design limits causal inference; unmeasured confounders (protocols, embryo quality, lifestyle) may remain. Implantation comparisons lacked formal statistical testing. Single-framework analysis may limit generalizability. Wider implications of the findings Clinically, prioritize BMI optimization pre-IVF, with targeted nutrition, metabolic workup, and enhanced luteal/early pregnancy monitoring at BMI extremes. AMH-based stimulation need not be heavily BMI-adjusted, and minor endometrial thickness differences likely do not explain outcome gaps. Trial registration number Yes
Zitieren
APA
Parmar, M., Jaiswal, S., Sherpa, C., Bhiwapurkar, A., Chandra, V., Murdia, K., Murdia, N., Sanagoudar, S., Mistari, W., & Suwalka, I. (2026). L26/P-458 The BMI curve for reproductive success: identifying the optimal and safe zone in 16000+ IVF cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.792
Vancouver
Parmar M, Jaiswal S, Sherpa C, Bhiwapurkar A, Chandra V, Murdia K, et al. L26/P-458 The BMI curve for reproductive success: identifying the optimal and safe zone in 16000+ IVF cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.792
BibTeX
@article{Parmar2026,
author = {Parmar, M. and Jaiswal, S. and Sherpa, C. and Bhiwapurkar, A. and Chandra, V. and Murdia, K. and Murdia, N. and Sanagoudar, S. and Mistari, W. and Suwalka, I.},
title = {L26/P-458 The BMI curve for reproductive success: identifying the optimal and safe zone in 16000+ IVF cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.792}
}
EUVIMED